315 related articles for article (PubMed ID: 19502655)
1. Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis.
Muñoz LE; Cordero P; Torres L; Sauceda AY; Flores JP; Segura JJ
Ann Hepatol; 2009; 8(2):123-8. PubMed ID: 19502655
[TBL] [Abstract][Full Text] [Related]
2. Irisin in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Anastasilakis AD; Geladari EV; Mantzoros CS
Metabolism; 2014 Feb; 63(2):207-17. PubMed ID: 24140091
[TBL] [Abstract][Full Text] [Related]
3. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
[TBL] [Abstract][Full Text] [Related]
4. Plasma adiponectin is decreased in nonalcoholic fatty liver disease.
Pagano C; Soardo G; Esposito W; Fallo F; Basan L; Donnini D; Federspil G; Sechi LA; Vettor R
Eur J Endocrinol; 2005 Jan; 152(1):113-8. PubMed ID: 15762194
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride levels and not adipokine concentrations are closely related to severity of nonalcoholic fatty liver disease in an obesity surgery cohort.
Kashyap SR; Diab DL; Baker AR; Yerian L; Bajaj H; Gray-McGuire C; Schauer PR; Gupta M; Feldstein AE; Hazen SL; Stein CM
Obesity (Silver Spring); 2009 Sep; 17(9):1696-701. PubMed ID: 19360015
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property.
Hyogo H; Yamagishi S; Maeda S; Kimura Y; Ishitobi T; Chayama K
Dig Liver Dis; 2012 Jun; 44(6):492-6. PubMed ID: 22265683
[TBL] [Abstract][Full Text] [Related]
9. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH).
Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E
J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485
[TBL] [Abstract][Full Text] [Related]
10. How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.
Machado MV; Coutinho J; Carepa F; Costa A; Proença H; Cortez-Pinto H
Eur J Gastroenterol Hepatol; 2012 Oct; 24(10):1166-72. PubMed ID: 22735605
[TBL] [Abstract][Full Text] [Related]
11. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
Sterling RK; Smith PG; Brunt EM
J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409
[TBL] [Abstract][Full Text] [Related]
12. The association between adipocytokines and biomarkers for nonalcoholic fatty liver disease-induced liver injury: a study in the general population.
Zelber-Sagi S; Ratziu V; Zvibel I; Goldiner I; Blendis L; Morali G; Halpern Z; Oren R
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):262-9. PubMed ID: 22246329
[TBL] [Abstract][Full Text] [Related]
13. Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.
Lemoine M; Ratziu V; Kim M; Maachi M; Wendum D; Paye F; Bastard JP; Poupon R; Housset C; Capeau J; Serfaty L
Liver Int; 2009 Oct; 29(9):1431-8. PubMed ID: 19422483
[TBL] [Abstract][Full Text] [Related]
14. UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity.
Labruna G; Pasanisi F; Nardelli C; Tarantino G; Vitale DF; Bracale R; Finelli C; Genua MP; Contaldo F; Sacchetti L
J Endocrinol Invest; 2009 Jun; 32(6):525-9. PubMed ID: 19474520
[TBL] [Abstract][Full Text] [Related]
15. Type 1 autoimmune hepatitis and adipokines: new markers for activity and disease progression?
Durazzo M; Niro G; Premoli A; Morello E; Rizzotto ER; Gambino R; Bo S; Musso G; Cassader M; Pagano G; Floreani A
J Gastroenterol; 2009; 44(5):476-82. PubMed ID: 19301087
[TBL] [Abstract][Full Text] [Related]
16. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
[TBL] [Abstract][Full Text] [Related]
17. [Value of serum osteoprotegerin in noninvasive diagnosis of nonalcoholic steatohepatitis].
Yang M; Liu Y; Zhou G; Guo X; Zou S; Liu S; Jiang L; Liu Y; Zhu L; Guo C; Zhao J
Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):96-101. PubMed ID: 26983475
[TBL] [Abstract][Full Text] [Related]
18. [The relationship between serum adiponectin level and serum alanine aminotransferase elevation in Korean male with nonalcoholic fatty liver disease].
Lee YS; Cho YK; Pae JC; Oh SY; Kang MS; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Lee WY; Oh KW; Yun EJ; Oh ES
Korean J Hepatol; 2006 Jun; 12(2):221-9. PubMed ID: 16804347
[TBL] [Abstract][Full Text] [Related]
19. Plasma insulin, leptin, adiponectin, resistin, ghrelin, and melatonin in nonalcoholic steatohepatitis patients treated with melatonin.
Gonciarz M; Bielański W; Partyka R; Brzozowski T; Konturek PC; Eszyk J; Celiński K; Reiter RJ; Konturek SJ
J Pineal Res; 2013 Mar; 54(2):154-61. PubMed ID: 22804755
[TBL] [Abstract][Full Text] [Related]
20. Relationship between serum leptin and fatty liver in Japanese male adolescent university students.
Tobe K; Ogura T; Tsukamoto C; Imai A; Matsuura K; Iwasaki Y; Shimomura H; Higashi T; Tsuji T
Am J Gastroenterol; 1999 Nov; 94(11):3328-35. PubMed ID: 10566739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
